Cormark Comments on Vitalhub's FY2025 Earnings (TSE:VHI)

Vitalhub Corp. (TSE:VHI - Free Report) - Analysts at Cormark cut their FY2025 earnings estimates for shares of Vitalhub in a note issued to investors on Tuesday, July 8th. Cormark analyst G. Fairweather now forecasts that the company will post earnings of $0.11 per share for the year, down from their previous forecast of $0.12. The consensus estimate for Vitalhub's current full-year earnings is $0.23 per share. Cormark also issued estimates for Vitalhub's FY2027 earnings at $0.45 EPS.

VHI has been the subject of a number of other reports. TD Securities lifted their price target on shares of Vitalhub from C$13.00 to C$14.00 and gave the company a "buy" rating in a research report on Monday, March 31st. National Bank Financial upgraded Vitalhub to a "strong-buy" rating in a report on Monday, June 9th. Scotiabank raised their price objective on Vitalhub from C$14.00 to C$14.50 and gave the company an "outperform" rating in a research note on Friday, June 20th. Raymond James Financial lifted their target price on Vitalhub from C$13.50 to C$14.00 and gave the stock an "outperform" rating in a research note on Friday, June 20th. Finally, National Bankshares set a C$14.00 price objective on Vitalhub and gave the company an "outperform" rating in a research note on Tuesday, June 10th. Six investment analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Buy" and a consensus price target of C$13.25.

Vitalhub Price Performance

TSE:VHI traded down C$0.08 on Wednesday, hitting C$12.45. 204,008 shares of the company's stock were exchanged, compared to its average volume of 127,570. The firm has a 50-day moving average price of C$10.85 and a 200-day moving average price of C$10.61. The company has a market cap of C$673.45 million, a P/E ratio of 202.49, a price-to-earnings-growth ratio of 1.18 and a beta of 1.26. Vitalhub has a 52 week low of C$6.74 and a 52 week high of C$12.72.

Insider Buying and Selling at Vitalhub

In other Vitalhub news, Director Francis Nelson Shen bought 25,000 shares of Vitalhub stock in a transaction on Friday, May 16th. The shares were bought at an average cost of C$10.23 per share, for a total transaction of C$255,750.00. 18.57% of the stock is currently owned by company insiders.

Vitalhub Company Profile

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.